The anti-CCR4 antibody mogamulizumab was recently developed [39, 40] and several therapeutic strategies are currently being tested, including immunostimulants, such as interferon and anti-PD-1/PDL-1 antibodies. … Continue reading The anti-CCR4 antibody mogamulizumab was recently developed [39, 40] and several therapeutic strategies are currently being tested, including immunostimulants, such as interferon and anti-PD-1/PDL-1 antibodies